Stocktoria
Summit Therapeutics Inc. SMMT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-10-14
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$10.9B
P / B16.5×
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | $0 | $0 | $705,000 | $1.8M |
| Operating income | — | -$226.0M | -$609.6M | -$72.1M | -$86.2M |
| Net income | -$1.1B | -$221.3M | -$614.9M | -$78.8M | -$88.6M |
| Operating cash flow | -$322.9M | -$142.1M | -$76.8M | -$41.6M | -$72.6M |
| Free cash flow | -$323.6M | -$142.2M | -$76.9M | -$42.2M | -$72.9M |
| Total assets | $751.2M | $435.6M | $202.9M | $664.2M | $113.4M |
| Total liabilities | $92.3M | $46.8M | $125.3M | $537.5M | $30.1M |
| Shareholders' equity | $658.9M | $388.7M | $77.7M | $126.7M | $83.3M |
| Ratios | |||||
| Operating margin | — | — | — | -10225.4% | -4764.3% |
| Net margin | — | — | — | -11174.8% | -4897.8% |
| FCF margin | — | — | — | -5986.7% | -4029.5% |
| Return on assets | -143.7% | -50.8% | -303.0% | -11.9% | -78.2% |
| Return on equity | -163.9% | -56.9% | -791.5% | -62.2% | -106.4% |
| Current ratio | 9.87 | 10.15 | 9.30 | 16.93 | 3.80 |
| Revenue growth | — | — | -100.0% | -61.0% | 110.3% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 801,086 | $15.2M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001599298 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.